Show simple item record

dc.contributor.authorNguyen, M
dc.contributor.authorJacobson, T
dc.contributor.authorTorres, J
dc.contributor.authorWann, A
dc.date.accessioned2021-08-15T23:39:06Z
dc.date.available2021-08-15T23:39:06Z
dc.date.issued2021-02-26
dc.identifier.citationNguyen, M., Jacobson, T., Torres, J. & Wann, A. (2021). Potential reduction of hospital stay length with outpatient management of low-risk febrile neutropenia in a regional cancer center. CANCER REPORTS, 4 (3), https://doi.org/10.1002/cnr2.1345.
dc.identifier.issn2573-8348
dc.identifier.urihttp://hdl.handle.net/11343/280347
dc.description.abstractBACKGROUND: Febrile neutropenia is a serious complication of chemotherapy. The Multinational Association for Supportive Care in Cancer (MASCC) risk index score identifies patients at low risk of serious complications. Outpatient management programs have been successfully piloted in other Australian metropolitan cancer centers. AIM: To assess current management of febrile neutropenia at our regional cancer center and determine potential impacts of an outpatient management program. METHOD: We performed a retrospective review of medical records for all patients admitted at our regional institution with febrile neutropenia between 1 January 2016, and 31 December 2018. We collected information regarding patient characteristics, determined the MASCC risk index score, and if low risk, we determined the eligibility for outpatient care and potential reduction in length of stay and cost benefit. RESULTS: A total of 98 hospital admissions were identified. Of these, 66 had a MASCC low-risk index score. Fifty-eight patients met the eligibility criteria for outpatient management. Seventy-one percent were female. The most common tumor type was breast cancer. Forty-eight percent were treated with curative intent. The median length of stay was 3 days. The median potential reduction in length of stay for each admission was 2 days. The total potential reduction in length of stay was 198 days. No admission resulted in serious complications. CONCLUSION: This review demonstrates a significant number of hospital admission days can be avoided. We intend to conduct a prospective pilot study at our center to institute an outpatient management program for such low-risk patients with potential reduction in hospital length of stay. This will have significant implications on health resource usage, service provision planning, and patient quality of life.
dc.languageEnglish
dc.publisherWILEY
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0
dc.titlePotential reduction of hospital stay length with outpatient management of low-risk febrile neutropenia in a regional cancer center
dc.typeJournal Article
dc.identifier.doi10.1002/cnr2.1345
melbourne.affiliation.departmentRural Clinical School
melbourne.affiliation.facultyMedicine, Dentistry & Health Sciences
melbourne.source.titleCancer Reports
melbourne.source.volume4
melbourne.source.issue3
dc.rights.licenseCC BY-NC-ND
melbourne.elementsid1507076
melbourne.contributor.authorTorres Corredor, Javier
dc.identifier.eissn2573-8348
melbourne.accessrightsOpen Access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record